Organogenesis jumps on S&P SmallCap 600 inclusion, Crocs dips on move
27/05/2021 13:22
** Shares of regenerative medicine co Organogenesis Holdings
Inc ORGO.O up ~12% at $18.69 premarket, while casual footwear
maker Crocs Inc's CROX.O stock off ~2% at $105.40 amid S&P
index shuffle
** ORGO to replace CROX in S&P SmallCap 600 index .SPCY
prior to open of trading on Weds, Jun 2 urn:newsml:reuters.com:*:nPn6sSGf5a
** CROX moving to S&P Midcap 400 .IDX to replace Cantel
Medical Corp CMD.N , which is being acquired by Steris plc
STE.N
** Avg Wall Street rating on ORGO is "strong buy" and median
PT is $26.50 - Refinitiv
** Avg analyst rating on CROX is "buy" and median PT is $125
- Refinitiv
** YTD, ORGO shares have soared ~121%. CROX shares up ~71%
in 2021
(Lance Tupper is a Reuters market analyst. The views expressed
are his own)
((lance.tupper.tr.com@reuters.net
lance.tupper@tr.com 1-332-219-1430))